Compare AZN & MS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AZN | MS |
|---|---|---|
| Founded | 1992 | 1924 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 276.3B | 278.0B |
| IPO Year | 1993 | N/A |
| Metric | AZN | MS |
|---|---|---|
| Price | $91.57 | $176.65 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 14 |
| Target Price | N/A | ★ $171.92 |
| AVG Volume (30 Days) | 5.8M | ★ 5.9M |
| Earning Date | 02-05-2026 | 01-15-2026 |
| Dividend Yield | 1.69% | ★ 2.31% |
| EPS Growth | 45.02 | ★ 48.48 |
| EPS | 6.02 | ★ 9.75 |
| Revenue | $58,127,000,000.00 | ★ $68,532,000,000.00 |
| Revenue This Year | $11.33 | $17.60 |
| Revenue Next Year | $6.08 | $5.64 |
| P/E Ratio | ★ $15.05 | $17.74 |
| Revenue Growth | 13.52 | ★ 17.59 |
| 52 Week Low | $61.24 | $94.33 |
| 52 Week High | $94.02 | $181.98 |
| Indicator | AZN | MS |
|---|---|---|
| Relative Strength Index (RSI) | 57.19 | 60.30 |
| Support Level | $89.85 | $172.58 |
| Resistance Level | $91.79 | $179.45 |
| Average True Range (ATR) | 1.30 | 3.41 |
| MACD | -0.26 | -0.37 |
| Stochastic Oscillator | 88.58 | 61.38 |
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.
Morgan Stanley is a massive global financial services firm, with offices in 42 countries and more than 80,000 employees as of year-end 2024. The firm cut its teeth in investment banking and institutional trading, where it maintains a strong presence today, but generates the lion share of its income from wealth and asset management franchises, where it boasted $7.9 trillion in client assets at the end of its most recent fiscal year. After reincorporation as a bank holding company in the wake of the global financial crisis, Morgan Stanley also boasts a top 10 banking franchise by deposits, with nearly $400 billion in customer deposits, predominately attributable to cash sweeps from its wealth management and brokerage businesses.